148 related articles for article (PubMed ID: 18458643)
41. ANCA, infectious endocarditis, glomerulonephritis and cryoglobulinemic vasculitis.
Lamprecht P; Gadola S; Schnabel A; Gross WL
Clin Nephrol; 1998 Jun; 49(6):389-90. PubMed ID: 9696437
[No Abstract] [Full Text] [Related]
42. Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.
Colucci G; Manno C; Grandaliano G; Schena FP
Clin Nephrol; 2011 Apr; 75(4):374-9. PubMed ID: 21426893
[TBL] [Abstract][Full Text] [Related]
43. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.
Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214
[TBL] [Abstract][Full Text] [Related]
44. Cold agglutinin disease and cryoglobulinemia.
Gertz MA
Clin Lymphoma; 2005 Mar; 5(4):290-3. PubMed ID: 15794868
[TBL] [Abstract][Full Text] [Related]
45. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
[TBL] [Abstract][Full Text] [Related]
46. B-cell depletion in the treatment of mixed cryoglobulinemia.
Sansonno D; Tucci FA; Montrone M; Troiani L; Sansonno L; Gatti P; Lauletta G
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S116-21. PubMed ID: 17936212
[TBL] [Abstract][Full Text] [Related]
47. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
Uppal R; Charles E; Lake-Bakaar G
J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
[TBL] [Abstract][Full Text] [Related]
49. Successful therapeutic use of rituximab in refractory membranous glomerulonephritis.
Cobo M; Hernández D; Rodriguez C; Pérez-Tamajón L
Clin Nephrol; 2006 Jul; 66(1):54-7. PubMed ID: 16878436
[TBL] [Abstract][Full Text] [Related]
50. Successful treatment of paraneoplastic cerebellar degeneration with Rituximab.
Esposito M; Penza P; Orefice G; Pagano A; Parente E; Abbadessa A; Bonavita V
J Neurooncol; 2008 Feb; 86(3):363-4. PubMed ID: 17924058
[No Abstract] [Full Text] [Related]
51. Successful treatment of refractory autoimmune hepatitis with rituximab.
D'Agostino D; Costaguta A; Álvarez F
Pediatrics; 2013 Aug; 132(2):e526-30. PubMed ID: 23821693
[TBL] [Abstract][Full Text] [Related]
52. [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis].
Akiyama K; Itabashi M; Shiohira S; Tsuruta Y; Shimizu A; Kamiyama M; Ishihara M; Otsubo S; Takei T; Taneda S; Honda K; Nitta K
Nihon Jinzo Gakkai Shi; 2011; 53(5):713-8. PubMed ID: 21842606
[TBL] [Abstract][Full Text] [Related]
53. Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.
Torrente-Segarra V; Lisbona-Pérez M; Rotes-Sala D; Castro-Oreiro S; Carbonell-Abelló J
Lupus; 2009 Mar; 18(3):270-2. PubMed ID: 19213868
[TBL] [Abstract][Full Text] [Related]
54. [Case report; a case of MALT lymphoma related cryoglobulinemic MPGN responded to combined chemotherapy with rituximab].
Kurashige M; Yokoo T; Miyazaki Y; Tsuboi N; Hayakawa H; Utsunomiya Y; Hosoya T
Nihon Naika Gakkai Zasshi; 2011 Apr; 100(4):1054-7. PubMed ID: 21626845
[No Abstract] [Full Text] [Related]
55. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
Cravedi P
G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
[TBL] [Abstract][Full Text] [Related]
56. Chronic neutropenia and cryoglobulinemic nephropathy: effectiveness of treatment.
Torra R; Darnell A; Botey A; Revert L
Nephron; 1995; 69(1):87-8. PubMed ID: 7891805
[No Abstract] [Full Text] [Related]
57. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
[TBL] [Abstract][Full Text] [Related]
58. Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II.
Moberg P; Charles JF; Respicio G; Venna SS; Rooney T
Cutis; 2010 Sep; 86(3):133-5. PubMed ID: 21049729
[TBL] [Abstract][Full Text] [Related]
59. [Cryoglobulinemic syndrome and autoimmune hepatitis].
Callejas JL; García-Núñez E; Fernández-Machín P; Fernández-Moyano A
Med Clin (Barc); 2002 Oct; 119(14):559. PubMed ID: 12421532
[No Abstract] [Full Text] [Related]
60. A revision on cryoglobulinaemia associated to neoplastic diseases.
Molina-Garrido MJ; Guillén-Ponce C
Clin Transl Oncol; 2007 Apr; 9(4):229-36. PubMed ID: 17462975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
